| ●Editorial | Clinical Research Risk Management Study Group | 376-7 | Full text | |
| ●Clinical Research Risk Management Study Group Digital Health Seminar The 2nd meeting on the future perspective of the pharmaceutical industry utilizing Real-World Data and Digital Health |
||||
| Artificial intelligence (AI) in medical devices and post-marketing machine learning | Suzuki T | 379-87 | Abstract | |
| Utilization of real world data to prove the value and safety of pharmaceuticals | Matsui N，Isshiki M | 389-98 | Abstract | |
| Awareness survey on Patient and Public Involvement (PPI) for Japanese drug development professional | Tsuda T，Okura M， Fukuta Y，Imamura K | 399-410 | Abstract | |
| ●Clinical Research Risk Management Study Group Seminar | ||||
| ・Methodology of risk-benefit assessment and standardization of voting options in IRBs: Learning from AAHRPP-accredited Samsung Medical Center Organizes and cooperators：Kurihara C; Clinical Research Risk Management Study Group; Mitsui Sumitomo Insurance; Rinsho Hyoka Kankokai, Inc. |
411-48 | Abstract | ||
| Opening Remarks | Kurihara C | 413-8 | Full text | |
| Part 1: Risk-benefit assessment according to study phase | Cho H （Interpreter: Rhee Y, Kim CY． Cooperation: Yun JS） | 419-38 | Full text | |
| Part 2: Standardization of voting options in IRBs: Approved, minor revision required, and not approved | Cho H （Interpreter: Rhee Y, Kim CY． Cooperation: Yun JS） | 439-48 | Full text | |
| ・The mission and experience of layperson members of the IRB/EC in Korea and Japan: Participating in discussion and voting as representatives of the citizenry, society, and patients Organizes and cooperators：Kurihara C; Clinical Research Risk Management Study Group; Mitsui Sumitomo Insurance; Rinsho Hyoka Kankokai, Inc. |
449-85 | Abstract | ||
| Opening remarks | Kurihara C，Rhee Y | 451-3 | Full text | |
| Part 1: Mission and experience in an Institutional Review Board in Korea | Yoo S （Interpreter: Rhee Y） | 454-66 | Full text | |
| Part 2: Mission and experience in Ethics Committees in Japan | Saeki H | 467-79 | Full text | |
| Part 3: Discussion with layperson members of IRB/EC in Korea and Japan | Yoo S，Rhee Y， Saeki H，Kurihara C | 480-5 | Full text | |
| ●Articles | ||||
| Single-session psychotherapy: Phenomenology of the critical turning point toward recovery | Saio T | 487-500 | Full text | |
| Conflict of interest disclosure backfires: Trend analysis on restriction of act and psychological experiments | Saio T，Kurihara C | 501-18 | Full text | |
| ●Forum | ||||
| Problems of psychiatric care in Nigeria | Imamura O，Aremu F | 519-22 | Full text | |
| ●Instructions for authors［Japanese］＆［English］ | 523-31 | Full text | ||
| ●Editor's note | Saio T | 533 | Full text | |